• ABOUT
  • PRIVACY
  • CONTACT
  • ADVERTISE
No Result
View All Result
KeralaNews 24x7
Monday, June 16, 2025
  • HOME
  • NEWS
  • ENTERTAINMENT
  • CRYPTO
  • SPORTS
    • OLYMPIC
    • CRICKET
    • FOOTBALL
    • KABADDI
    • BASKETBALL
    • TENNIS
    • WWE
  • TECHNOLOGY
  • HEALTH
  • EVENTS
  • DEALS
    • SPECIAL DEALS
  • BLOG
    • BUSINESS
    • FINANCE
    • DIGITAL MARKETING
    • EDUCATION
    • LIFE STYLE
    • REAL ESTATE
    • ART
    • ADULT
    • CASINO
    • FASHION
    • GAMES
    • LAW AND ORDER
    • TRAVEL
  • HOME
  • NEWS
  • ENTERTAINMENT
  • CRYPTO
  • SPORTS
    • OLYMPIC
    • CRICKET
    • FOOTBALL
    • KABADDI
    • BASKETBALL
    • TENNIS
    • WWE
  • TECHNOLOGY
  • HEALTH
  • EVENTS
  • DEALS
    • SPECIAL DEALS
  • BLOG
    • BUSINESS
    • FINANCE
    • DIGITAL MARKETING
    • EDUCATION
    • LIFE STYLE
    • REAL ESTATE
    • ART
    • ADULT
    • CASINO
    • FASHION
    • GAMES
    • LAW AND ORDER
    • TRAVEL
No Result
View All Result
News 24x7
No Result
View All Result

Aurobindo Pharma’s Unit-V Facility in Telangana Cleared by US FDA with Minor Observations

Kaiden Mills by Kaiden Mills
6 months ago
Reading Time: 2 mins read
0
0
0
SHARES
1
VIEWS
FBXLinkedinWhatsAppTelegram

Aurobindo Pharma Ltd announced that the United States Food and Drug Administration (FDA) has completed its inspection of Unit-V, a manufacturing facility for active pharmaceutical ingredients (APIs) operated by its subsidiary Apitoria Pharma Private Ltd. The inspection, conducted between December 9 and December 17, 2024, concluded with two procedural observations. The company assured stakeholders that it would address the issues within the prescribed timeline.

FDA Inspection Details and Observations

The inspection focused on the Unit-V facility in Telangana, a critical hub for Aurobindo Pharma’s API production. The two observations cited by the FDA were procedural and did not involve serious compliance issues. Aurobindo Pharma expressed confidence in resolving the observations promptly.

In a statement, the company reaffirmed its commitment to keeping investors and stock exchanges informed about future developments:

The inspection concluded with 02 observations. The observations are procedural in nature and will be addressed within the allotted time. We will keep the stock exchanges updated if there is any additional information relevant to the foregoing in the future.

The smooth resolution of these observations is pivotal for maintaining the company’s export operations, especially given the FDA’s rigorous scrutiny of pharmaceutical manufacturing facilities worldwide.

Aurobindo Pharma Telangana manufacturing plant

Financial Performance Shows Resilience

While the FDA inspection drew attention to compliance, Aurobindo Pharma’s recent financial performance underscored the company’s market strength. For the second quarter ending September 2024, the company posted an impressive year-on-year (YoY) net profit growth of 8.6%, reaching ₹817 Crore. This growth was largely fueled by robust sales in European and other international markets.

In comparison, the net profit for the same quarter in the previous fiscal year stood at ₹752 Crore. However, quarter-on-quarter (QoQ), the company recorded an 11% dip in profits. Despite this short-term decline, the company’s YoY revenue grew by 8% to ₹7,796 Crore in Q2 FY25, indicating sustained momentum in its core business.

Key Takeaways from the Inspection and Financial Trends

Aurobindo Pharma’s ability to address FDA observations while maintaining financial growth highlights its resilience in a competitive industry. Some key points include:

  • Procedural Observations: These types of observations typically involve documentation or standard operating procedures rather than significant quality control lapses.
  • Steady Revenue Growth: The company’s expansion in Europe and other emerging markets continues to be a strong growth driver.
  • Quarterly Profit Dip: While QoQ profitability decreased, this may reflect temporary operational challenges or currency fluctuations.

What’s Next for Aurobindo Pharma?

The FDA’s scrutiny of pharmaceutical facilities is often viewed as a litmus test for global compliance standards. Aurobindo Pharma’s proactive approach to resolving procedural observations will likely strengthen its position in regulated markets like the United States.

Moreover, with consistent sales growth in international markets, the company remains well-poised for long-term expansion. Investors and stakeholders will closely monitor the resolution of the FDA observations and await updates on further developments.

ShareTweetShareSendShare
Kaiden Mills

Kaiden Mills

Kaiden Mills is a talented content writer who wields words with precision to craft engaging and informative pieces. With a keen eye for detail and a passion for research, he consistently delivers high-quality content that educates and entertains. Kaiden's dedication to his craft makes him a valuable contributor to the world of written communication.

Related Posts

mediatek dimensity 9500 geekbench processor chipset

MediaTek’s Dimensity 9500 Surfaces on Geekbench With Cortex-X930 Core and Mali-G1-Ultra GPU

6 hours ago
will-smith-christopher-nolan-inception-movie-promo

Will Smith Admits He Turned Down Inception Because He Didn’t Understand It

6 hours ago
meesho

NCLT Clears Meesho’s Shift Back to India as IPO Countdown Begins

6 hours ago
google gemini code assist vscode plugin screenshot

Google’s Gemini Code Assist Gets Major Upgrade with Gemini 2.5 Integration

2 days ago
Nagarjuna Coolie tiger walk

Nagarjuna Channels His Inner Tiger for ‘Coolie’—Lokesh Kanagaraj’s Vision Transforms the Star

3 days ago
redmi k80 ultra and redmi k pad teaser launch

Xiaomi Teases REDMI K80 Ultra and K Pad, Promises Flagship Specs Without Flagship Prices

3 days ago
maruti suzuki factory gujarat wikimedia

Maruti Suzuki’s Gujarat Merger Gets NCLT Nod, Paving Way for Simpler Corporate Structure

4 days ago
manpowergroup employment outlook survey india 2025

India’s Job Market Stays Strong With 42% Hiring Outlook, Energy Sector Steals the Show

4 days ago

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

No Result
View All Result

ADVERTISEMENTS

(adsbygoogle = window.adsbygoogle || []).push({});

POPULAR ARTICLES

Checkbook

How to Order a Checkbook from Chase: A Complete Guide

1 year ago
Infinix Hot 8 Settings

Infinix Hot 8 Settings: How to Customize Your Phone for the Best Experience?

2 years ago
Birdie Golf

What is a Birdie Golf: Understanding Scoring and History

1 year ago
Pool Table Balls

How to Set Up a Pool Table Balls: Step-by-Step Guide

1 year ago
CRED fintech app India smartphone interface

CRED’s $3.5 Billion Reset: Fintech Unicorn Raises $72M Amid Shifting Valuations

6 days ago
eSports

Just How Big Will eSports Be?

8 years ago
Iontophoresis Device

Iontophoresis Device, the Best Treatment for Excessive Sweating

8 years ago
NOW Entertainment soon to Start Selling American Hustle82 Apparel

NOW Entertainment soon to Start Selling American Hustle82 Apparel

8 years ago
E-cigs Products in Classrooms

Is It Right to Ban the Juul and Other E-cigs Products in Classrooms?

8 years ago
Ryan Van Wagenen

Ryan Van Wagenen Expects Continued Growth for the Silicon Slopes

7 years ago
Facebook Twitter Youtube

ABOUT US

The KeralaNews 24×7 website is for desi entertainment lovers across India, USA and UK. We often cover breaking News & Trending topics in India and have been referenced by numerous media outlets. Follow us on our Social media profiles for the latest updates and news.

Contents produced in this website are subjected to DigitalCopyRight Law.

© 2023 KeralaNews 24×7 – Website Designed by VISION

WEBSITE STATS

  • Google News Approved
  • 1,00,000 Traffic/Month
  • Domain Authority – 25
  • 70% Traffic from Google

ADVERTISE WITH US

If you are looking to advertise your business or website, feel free to contact us at ceo.keralanews247@gmail.com

We accept following form of advertisements,

  • Banner Ads
  • Contextual Links
  • Guest Posts
  • Sponsored Posts

SEARCH

No Result
View All Result

MORE INFO

  • ABOUT
  • PRIVACY
  • CONTACT
  • ADVERTISE

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • NEWS
  • ENTERTAINMENT
  • CRYPTO
  • SPORTS
    • OLYMPIC
    • CRICKET
    • FOOTBALL
    • KABADDI
    • BASKETBALL
    • TENNIS
    • WWE
  • TECHNOLOGY
  • HEALTH
  • EVENTS
  • DEALS
    • SPECIAL DEALS
  • BLOG
    • BUSINESS
    • FINANCE
    • DIGITAL MARKETING
    • EDUCATION
    • LIFE STYLE
    • REAL ESTATE
    • ART
    • ADULT
    • CASINO
    • FASHION
    • GAMES
    • LAW AND ORDER
    • TRAVEL

© 2023 KeralaNews 24x7 - Website Designed by VISION

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.